| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2025-04-08 15:58:30 UTC |
|---|
| Updated at | 2025-07-24 18:35:59 UTC |
|---|
| NP-MRD ID | NP0350923 |
|---|
| Natural Product DOI | https://doi.org/10.57994/3908 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Comp5 |
|---|
| Description | Comp5 was first documented in 2021 (PMID: 33495861). Based on a literature review a small amount of articles have been published on Comp5 (PMID: 39615602) (PMID: 38114011) (PMID: 37702159) (PMID: 36816262). |
|---|
| Structure | CC(=O)NC(=N)N[C@@H]1CC[C@@H]2N1C(=O)[C@@H]1C[C@@]3(O)C4=C(N[C@]3(N1C2=O)C(C)(C)C=C)C=CC=C4 InChI=1S/C24H30N6O4/c1-5-22(3,4)24-23(34,14-8-6-7-9-15(14)28-24)12-17-19(32)29-16(20(33)30(17)24)10-11-18(29)27-21(25)26-13(2)31/h5-9,16-18,28,34H,1,10-12H2,2-4H3,(H3,25,26,27,31)/t16-,17-,18-,23+,24-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C24H30N6O4 |
|---|
| Average Mass | 466.5420 Da |
|---|
| Monoisotopic Mass | 466.23285 Da |
|---|
| IUPAC Name | N-{N-[(1S,4S,7S,10S,12R)-12-hydroxy-1-(2-methylbut-3-en-2-yl)-3,9-dioxo-2,8,19-triazapentacyclo[10.7.0.0^{2,10}.0^{4,8}.0^{13,18}]nonadeca-13(18),14,16-trien-7-yl]carbamimidoyl}acetamide |
|---|
| Traditional Name | N-{N-[(1S,4S,7S,10S,12R)-12-hydroxy-1-(2-methylbut-3-en-2-yl)-3,9-dioxo-2,8,19-triazapentacyclo[10.7.0.0^{2,10}.0^{4,8}.0^{13,18}]nonadeca-13(18),14,16-trien-7-yl]carbamimidoyl}acetamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(=O)NC(=N)N[C@@H]1CC[C@@H]2N1C(=O)[C@@H]1C[C@@]3(O)C4=C(N[C@]3(N1C2=O)C(C)(C)C=C)C=CC=C4 |
|---|
| InChI Identifier | InChI=1S/C24H30N6O4/c1-5-22(3,4)24-23(34,14-8-6-7-9-15(14)28-24)12-17-19(32)29-16(20(33)30(17)24)10-11-18(29)27-21(25)26-13(2)31/h5-9,16-18,28,34H,1,10-12H2,2-4H3,(H3,25,26,27,31)/t16-,17-,18-,23+,24-/m0/s1 |
|---|
| InChI Key | UDOLCGIXLAJSQO-HRWDQCIQSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| HMBC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | niwakanji0218@gmail.com | University of California, Los Angeles | Kanji Niwa | 2025-04-08 | View Spectrum | | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | niwakanji0218@gmail.com | University of California, Los Angeles | Kanji Niwa | 2025-04-08 | View Spectrum | | COSY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | niwakanji0218@gmail.com | University of California, Los Angeles | Kanji Niwa | 2025-04-08 | View Spectrum | | ROESY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | niwakanji0218@gmail.com | University of California, Los Angeles | Kanji Niwa | 2025-04-08 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | niwakanji0218@gmail.com | University of California, Los Angeles | Kanji Niwa | 2025-04-08 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | niwakanji0218@gmail.com | University of California, Los Angeles | Kanji Niwa | 2025-04-08 | View Spectrum |
| | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Classification | Not classified |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Krol W, Machelak W, Zielinska M: Positive allosteric modulation of micro-opioid receptor - A new possible approach in the pain management? Biochem Pharmacol. 2025 Feb;232:116686. doi: 10.1016/j.bcp.2024.116686. Epub 2024 Nov 28. [PubMed:39615602 ]
- Waqas M, Ullah S, Halim SA, Rehman NU, Ali A, Jan A, Muhsinah AB, Khan A, Al-Harrasi A: Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2. Int J Biol Macromol. 2024 Feb;258(Pt 1):128812. doi: 10.1016/j.ijbiomac.2023.128812. Epub 2023 Dec 17. [PubMed:38114011 ]
- Naskar A, Bhanja KK, Roy RK, Patra N: Structural insight into G2019S mutated LRRK2 kinase and brain-penetrant type I inhibitor complex: a molecular dynamics approach. J Biomol Struct Dyn. 2024;42(19):10129-10149. doi: 10.1080/07391102.2023.2255675. Epub 2023 Sep 13. [PubMed:37702159 ]
- Rampogu S, Shaik B, Kim JH, Jung TS, Ha MW, Lee KW: Explicit molecular dynamics simulation studies to discover novel natural compound analogues as Mycobacterium tuberculosis inhibitors. Heliyon. 2023 Jan 30;9(2):e13324. doi: 10.1016/j.heliyon.2023.e13324. eCollection 2023 Feb. [PubMed:36816262 ]
- Khan S, Fakhar Z, Ahmad A: Targeting ebola virus VP40 protein through novel inhibitors: exploring the structural and dynamic perspectives on molecular landscapes. J Mol Model. 2021 Jan 25;27(2):49. doi: 10.1007/s00894-021-04682-8. [PubMed:33495861 ]
|
|---|